NM_000535.7(PMS2):c.675A>C (p.Glu225Asp) AND Lynch syndrome

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Dec 13, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003998642.2

Allele description [Variation Report for NM_000535.7(PMS2):c.675A>C (p.Glu225Asp)]

NM_000535.7(PMS2):c.675A>C (p.Glu225Asp)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.675A>C (p.Glu225Asp)

HGVS:

NC_000007.14:g.5999138T>G
NG_008466.1:g.14969A>C
NM_000535.6:c.675A>C
NM_000535.7:c.675A>CMANE SELECT
NM_001322003.2:c.270A>C
NM_001322004.2:c.270A>C
NM_001322005.2:c.270A>C
NM_001322006.2:c.675A>C
NM_001322007.2:c.357A>C
NM_001322008.2:c.357A>C
NM_001322009.2:c.270A>C
NM_001322010.2:c.270A>C
NM_001322011.2:c.-259A>C
NM_001322012.2:c.-259A>C
NM_001322013.2:c.133-1715A>C
NM_001322014.2:c.675A>C
NM_001322015.2:c.366A>C
NP_000526.2:p.Glu225Asp
NP_001308932.1:p.Glu90Asp
NP_001308933.1:p.Glu90Asp
NP_001308934.1:p.Glu90Asp
NP_001308935.1:p.Glu225Asp
NP_001308936.1:p.Glu119Asp
NP_001308937.1:p.Glu119Asp
NP_001308938.1:p.Glu90Asp
NP_001308939.1:p.Glu90Asp
NP_001308943.1:p.Glu225Asp
NP_001308944.1:p.Glu122Asp
LRG_161t1:c.675A>C
LRG_161:g.14969A>C
NC_000007.13:g.6038769T>G
NM_000535.5:c.675A>C
NM_000535.7:c.675A>C
NR_136154.1:n.762A>C

Protein change:

E119D

Links:

dbSNP: rs876661233

NCBI 1000 Genomes Browser:

rs876661233

Molecular consequence:

NM_001322011.2:c.-259A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-259A>C - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.133-1715A>C - intron variant - [Sequence Ontology: SO:0001627]
NM_000535.7:c.675A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322003.2:c.270A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322004.2:c.270A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322005.2:c.270A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.675A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322007.2:c.357A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322008.2:c.357A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322009.2:c.270A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322010.2:c.270A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.675A>C - missense variant - [Sequence Ontology: SO:0001583]
NM_001322015.2:c.366A>C - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.762A>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Observations:

Condition(s)

Name:: Lynch syndrome
Identifiers:: MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004839937	All of Us Research Program, National Institutes of Health	criteria provided, single submitter (ACMG Guidelines, 2015)	Uncertain Significance (Dec 13, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004839937

All of Us Research Program, National Institutes of Health

criteria provided, single submitter

(ACMG Guidelines, 2015)

Uncertain Significance
(Dec 13, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	2	not provided	not provided	108544	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Details of each submission

From All of Us Research Program, National Institutes of Health, SCV004839937.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	2	not provided	not provided	clinical testing	PubMed (1)

Description

This missense variant replaces glutamic acid with aspartic acid at codon 225 of the PMS2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with PMS2-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	108544	not provided	not provided		2	not provided	not provided	not provided

Last Updated: Jun 17, 2024

ClinVar

Relating variation to medicine